tm logo

Monitor this mark

View On USPTO

SOURCECF
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 26 Dec 2014

Last Applicant/ Owned by

APTALIS PHARMA US, INC.

100 SOMERSET CORPORATE BLVD

BRIDGEWATER

NJ

08807

Serial Number

78213801 filed on 12th Feb 2003

Registration Number

2846834 registered on 25th May 2004

in the Principal Register

Correspondent Address

Christopher Serbagi

Christopher Serbagi

488 Madison Avenue, Suite 1120

New York NY 10022

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SOURCECF

Pharmaceutical preparation for the treatment of, and the alleviation of symptoms associated with, cystic fibrosis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparation for the treatment of, and the alleviation of symptoms associated with, cystic fibrosis

First Use Date in General

02th Jun 2003

First Use Date in Commerce

02th Jun 2003

Mark Details

Serial Number

No 78213801

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
26th Dec 2014CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
16th Sep 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16th Sep 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12th Feb 2014ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06th Nov 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
30th Oct 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
03rd Oct 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
23rd Feb 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
16th Feb 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
17th Mar 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL